Infectious Disease
Liver Abscess
7
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Liver abscess is an early-stage landscape with 7 programs across 3 companies. The most active players are Bayer, Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. 6 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 31
Analysis
Trial Status
4
clinical trials
Completed2 · 50%
Recruiting1 · 25%
Unknown status1 · 25%
Clinical Trials
Trial Activity
Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess
Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 3·NCT03969758·140 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)